Be part of the grassroots support network!
M. speciosa has been under scrutiny since it became a widely popular herbal product outside of it’s native Southeast Asia. The DEA had marked it as a possible “concern” (as they had attempted with kava root) and when a case couldn’t be found, the ball was passed to the FDA. FDA restrictions on import were just the start of the trials for this benign superplant.
Most recently, as of September 2016, the DEA attempted to designate mitragyna leaf powder a schedule 1 drug in the USA. According to scheduling that means the plant could have “no medical value” and a “high likelihood of abuse and addiction.” To put this in perspective, cocaine and methamphetamine are considered to have medicinal value, whereas schedule 1 would put this beneficent botanical in the same legal category as heroin.
M. speciosa has a voice, though, in the form of the herbal community at large. Despite overwhelming support of the plant during the DEA’s comment period, it’s most likely that we will see more attempts to limit its availability for those who need it most. It’s not over yet; it may have just begun. Get involved with the Botanical Education Alliance, American Kratom Association, Kratom United and find out how you can support it’s continued legality and accessibility.
Write your legislators.
These are all the committees that have jurisdiction over the DEA. House and Senate Judiciary being most important. Message all members!
House Judiciary https://judiciary.house.gov/ subcommittee/full-committee/
Senate Judiciary https://www.judiciary.senate. gov/about/members
House Energy and Commerce https://energycommerce.house. gov/about-ec/energy-commerce- committee-members
House Commerce, Justice, and Science Appropriations Subcommitteehttps://appropriations.house. gov/about/members/ commercejusticescience.htm
Senate Commerce, Justice, and Science Appropriations Subcommitteehttps://www.appropriations. senate.gov/subcommittees/ commerce-justice-science-and- related-agencies
House Oversight and Gov’t Reform Committee https://oversight.house.gov/ subcommittee/full-committee/
Senate Homeland Security and Governmental Affairs Committeehttps://www.hsgac.senate.gov/about
U.S. Department of Justice https://www.justice.gov/doj/webform/your-message-department-justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001
•Department Comment Line: 202-353-1555
•Department of Justice Main Switchboard: 202-514-2000
Peter J. Kadzik
Assistant Attorney General
Office of Legislative Affairs ph: 202-514-2141
Intergovernmental Affairs and Public Liaison ph: 202-514-3465
You can send a message to the Department of Justice HERE
Michael J Lewis,
Office of Diversion Control, Drug Enforcement Administration
8701 Morrissette Drive, Springfield, Virginia 22152; ph: 202-598–6812.
Also please contact the assistant secretary of
HHS, Karen B. DeSalvo, MD, MPH, MSc
Acting Assistant Secretary for Health
ASH@hhsgov ph: 202-690-7694
Assistant Secretary for Legislation (ASL) ph: 202-690-7627
Assistant Secretary for Public Affairs (ASPA) ph: 202-690-7850
Acting Assistant Secretary for Administration (ASA)
HHS Office of the Secretary